ERG expression can predict the outcome of docetaxel combined with androgen deprivation therapy in metastatic hormone-sensitive prostate cancer

Küronya, Zsófia, Sükösd, Farkas, Varga, Linda, Bíró, Krisztina, Gyergyay, Fruzsina, Géczi, Lajos, Nagyiványi, Krisztián András, Jorgo, Kliton, Szarvas, Tibor, Kovács, Ágnes, Laczkó, Ibolya, Varga, Zoltán, Pósfai, Boglárka, Pepó, Judit, Maráz, Anikó: ERG expression can predict the outcome of docetaxel combined with androgen deprivation therapy in metastatic hormone-sensitive prostate cancer.
UROLOGIC ONCOLOGY: SEMINARS AND ORIGINAL INVESTIGATIONS, 37 (4). 289.e1-289.e9. ISSN 1078-1439 (2019)

[img] Text
30476714.pdf - Published Version
Korlátozott. Registered users only

Download (1MB) | Request a copy
Item Type: Article
Journal or Publication Title: UROLOGIC ONCOLOGY: SEMINARS AND ORIGINAL INVESTIGATIONS
Date: 2019
Volume: 37
Number: 4
Page Range: 289.e1-289.e9
ISSN: 1078-1439
Faculty: Faculty of Medicine
Institution: Szegedi Tudományegyetem
MTMT id: 30476714
DOI id: https://doi.org/10.1016/j.urolonc.2018.12.007
Date Deposited: 2019. Dec. 20. 11:06
Last Modified: 2019. Dec. 20. 11:06
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/17760

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year